Pharmaceuticals(41)
-
Design of a Multivalent mRNA Vaccine to Protect Against Multiple Variants (No. T4-2136)
The constant emergence of new variants threatens the success of the mRNA vaccines developed against SARS-CoV-2. Therefore, there is an urgent need to develop a vaccine that will provide immunity against multiple variants – both existing and potential. Prof. ... Read more14762 -
Novel Combination Therapy For Improved Management of Depression (No. T4-2129)
Psychiatric disorders, especially major depressive disorder (MDD), are leading causes of disability and premature death across the globe, with patients showing a heightened risk of self-harm and suicidal ideation. Prof. ... Read more6097 -
Modulating Weight Gain and Loss by Understanding the Mechanism of Smoking Related Weight Changes (No. T4-2078)
Of the approximately 30 million adult smokers in the U.S, more than half report attempting to quit smoking every year. However, smoking cessation-associated weight gain (SCWG) constitutes a major obstacle to smoking withdrawal. ... Read more17357 -
Treatment for Ewing Sarcoma Using ETS Proteins (No. T4-2068)
Ewing sarcoma (ES) is a common bone malignancy in children and young adolescents which is usually treated by systemic chemotherapy. In about 25% of the cases, cancer has already spread to other parts of the body at the time of diagnosis. ... Read more6154 -
Inhibitory Proteins for 20S Proteasome Regulation as Cancer Treatment (No. T4-2065)
Proteasomal protein degradation is crucial in maintaining cellular integrity and in regulating key cellular processes including cell cycle, proliferation and cell death. ... Read more6139 -
Increasing Immunotherapy Efficacy of Anti PD-L1 (No. T4-2059)
Immunotherapy has revolutionized cancer treatment by activating the immune system to attack tumor cells. However, notable limitations remain, including differential responses between individuals and cancer types. Dr. ... Read more17039 -
Peptides for Treating Alzheimer's Disease (No. T4-2057)
Alzheimer's Disease (AD) is an age-associated neurodegenerative disorder characterized clinically by a decline in cognitive function. It is the most common type of dementia, with 5.8 million Americans living with AS in 2020. ... Read more
Ruth Arnon
Faculty of Biology6160 -
Safer CAR-T Cell Platform (No. T4-2033)
Chimeric Antigen Receptor (CAR)-T Cell Therapy is a personalized treatment for cancer in which the patient's T cells are genetically engineered to express a synthetic receptor that binds a tumor antigen. ... Read more6124 -
Biologic Drug for Prevention and Treatment of COVID-19 (No. T4-2024)
Combat against COVID-19 is still ongoing worldwide. ... Read more6027 -
Small Molecules for Treatment of Huntington's Disease and Related Disorders (No. T4-1947)
Trinucleotide repeats expansion disorders (TREDs) are a set of diseases in which repetitions of short DNA segments (three nucleotides) occur and accumulate in the genome. ... Read more6193
Pages
